Get more information on In Vitro Fertilization (IVF) Market Market - Request Sample Report
The In Vitro Fertilization (IVF) Market was valued USD 18.82 billion in 2023, anticipated to reach USD 35.83 billion by 2032 with a compound annual growth rate at 7.47% during the forecast period 2024-2032.
Increasing infertility cases across the globe is the major factor for the growth as well as acceleration of in vitro fertilization market. According to the World Health Organization (April 2023), approximately 17.5% of adults worldwide experience infertility. This highlights a significant global need for accessible fertility care. Men and women are equally affected by infertility, with male infertility contributing to roughly 30% of cases (American Pregnancy Association). Several factors, including the trend towards later marriage and childbearing, are contributing to a rise in the use of In Vitro Fertilization (IVF) procedures. It also allows the groundbreaking of saving your eggs to postpone childbearing in favor of pursuing your career for women. The reason for the growth of this market is due to increased dependency on fertility treatments.
In the United States, in vitro fertilization (IVF) demand is on the rise because of increasing infertility rates with approximately 1 in 10 women and men experiences difficulties conceiving naturally. This statistic of 10% is so substantial that in essence has led to an increase demand for assisted reproductive technology including IVF. Also, as family services become available around the campus. As 2021 clearly demonstrated, a full one in eight women end up using them; the number of births accomplished through ART exceeded 86000. IVF procedures is the king, making up over 99% of Assisted reproductive technology (ART). All of that amounts to the IVF process and it makes evident just why so many people are relying on this method when they cannot fall pregnant naturally.
Better techniques in IVF such as egg/sperm cryopreservation, vitrification (rapid freezing), and assisted hatching also support better success rates. Similarly, the advent of newer techniques like Percutaneous Epididymal Sperm Aspiration (PESA) and Testicular Sperm Extraction (TESE) is helping us in retrieving sperm from males. The most recent example of this is the merger between AI solutions company AIVF Ltd. and Genea Biomedx (medical devices), which sees both leveraging their technologies to offer a personalized IVF system that's cost-efficient, as well meeting more systemic needs. Rising trend of medical tourism making it possible for low budget overseas IVF treatment.
Surging Need for IVF Solutions Amidst Growing Infertility
Increasing environmental pollution, changes in genetics and an increase in age-related problems and comorbidities- especially it is one of the main global issues called infertility. The increased number of infertility cases further heightens the demand for IVF treatments as couples look to address their struggles with conception. Better and improved IVF techniques are leading to a greater number of successes, obviously for all the reasons married couple with infertility affecting them heading towards this technology. New methods that are more patient-friendly such as needle-free IVF procedures could also add to demand. There are public service campaigns that raise awareness about issues of fertility, available methods (e.g. IVF) and contributing factors (most commonly postponement). We expect that this growing public awareness will lead to more couples seeking treatment. The launch of new IVF facilities and the development of improved ART services provide more options for patients and improve accessibility to treatment.
High Costs and Limited Insurance Coverage
A single IVF cycle is usually priced between USD 15,000 and USD 30,000 but the costs could reach over USD 40,000 if more than one treatment (cycle) are needed to achieve a successful pregnancy. IVF treatment is often not covered by insurance, making it extremely unaffordable for many lower-income individuals. Only 15 states currently require private insurance to cover IVF, but these mandates do not apply to self-insured employer plans which are used by most workers. Adding to the inaccessibility, Medicaid coverage also varies by state for fertility services and is optional.
Disposable Devices
Culture Media
Cryopreservation Media
Embryo Culture Media
Ovum Processing Media
Sperm Processing Media
Equipment
Sperm Analyzer Systems
Imaging Systems
Ovum Aspiration Pumps
Micromanipulator Systems
Incubators
Gas Analyzers
Laser Systems
Cryosystems
Sperm Separation Devices
IVF Cabinets
Anti-vibration Tables
Witness Systems
Other
The culture media market dominated the in vitro fertilization (IVF) with nearly 60.20% in 2023 of its revenue shares contributed by this segment. This dominance is driven by two reasons: every strong financial input to the R&D in this field and continuous improvements of culture media itself. FUJIFILM Irvine Scientific, for instance launched a specialised oil to improve embryo culture after the cut-off (July 2022).
Else, the Disposable Devices segment is estimated to grow at highest CAGR in upcoming years. The growth is due to the launch of disposable tools including slides, needles and chambers by corporates. The first generation of these products deal with the key requirements in sterility and compliance as part of an IVF process. The utilization of some other disposable slides (sperm counting), imaging-based systems, for the isolation of top motile sperm or using microchips has already entered into present mainstream.
Need any customization research on In Vitro Fertilization (IVF) Market Market - Enquiry Now
Fresh Donor
Frozen Donor
Fresh Non-donor
Frozen Non-donor
The in vitro fertilization (IVF) market leader in egg source is frozen, non-donor eggs with 59.31% in 2023. This dominance is predicted to continue with the fastest growth rate due to their affordability compared to fresh, non-donor eggs and the minimally invasive retrieval process. However, the fresh donor egg segment shows promise for significant growth. A 2020 report indicates that nearly 1,500 ART cycles used fresh donors, resulting in a high live-birth delivery rate. This suggests a rising demand for fresh donor eggs.
Challenges cloud the fresh donor segment while some clinics offer risk-sharing plans for multiple cycles with fresh embryos, concerns linger about the inconsistency of sperm donor screening. Regulations surrounding fresh sperm donation also vary, with some regions mandating quarantine periods for HIV testing. Additionally, limited public funding for fertility treatments using donated gametes for same-sex couples and single parents in certain areas creates another obstacle.
Fertility Clinics
Hospitals & Others Setting
Fertility clinics are leading the market with 63.22% in 2023 revenue share. This dominance originates from various causes. For starters, growing adoption of assisted reproductive technologies (ART) means rising requirement for dedicated fertility clinics. The expansion in the number of these clinics and ART centers is a vast improvement that date we thought was long way off but we now need to focus on improving access for patients. The third reason for you to consider visiting a fertility clinic is that they can be more affordable than hospitals. On the other hand, these clinics usually have expert professionals on board which might mean that you end up with better results and fewer side effects. Similarly, hospitals are full of sick people, making the chances for Hospital-Acquired Infections (HAIs) far more likely than in a quality-controlled environment such as a fertility clinic.
While those settings still have a place in the in vitro fertilization market, given clinics' dominance already existing trends are forecast to continue. Some patients benefit from a broader-spectrum of care offered at many multispecialty hospitals that provide IVF services as well. Non-hospital-based IVF treatments are usually cheaper since they do not require the typically expensive labor regimen with highly skilled staff employed to conduct these procedures (which is what bins up price of training and employing already pricey specialist-surgeon-doctors). The cost point is clear, in particular for developed countries.
Regional Analysis
Europe will be at the helm of global in vitro fertilization market chart, holding 36.7% share in revenues procured through sales of every IVF product sold world over in 2023 The strategic regime of this power results from a mixture of circumstances. Americans looking for IVF at an affordable price visit countries like the Czech Republic on medical tourism trips. In Europe, the innovation continues with approval of Fairtility's AI-based embryo assessment tool received in July 2022 to bring great promise for better IVF success rates.
The in vitro fertilization market is also lucrative for growth in the coming years especially in North America. Infertility rates are notoriously increasing, and those numbers may be growing due to unhealthy lifestyle factors like eating habits, stress or even obesity. The in vitro fertilization market is expected to be driven by standardization of procedures, automation in the field, and government funding for egg & sperm storage. In addition, the large number of couples in North America who are unable to conceive without help (one in eight), creates new demand.
A similar trend can also be observed in the Asia Pacific in vitro fertilization market. Medical tourism also helps in its growth, similar to Europe. Moreover, a rising number of foreign enterprises providing products in order to non-urban parts within the region is usually driving market growth. Transformative regulatory reforms to create a fertile environment for IVF, decreasing birth rates (expected at 2.1 children per woman in the year 2022) and an ageing population are some of the factors anticipated to propel market growth within Asia Pacific region. Moreover, numerous organizations like Asia Pacific Initiative on Reproduction (ASPIRE) are piling efforts in creating awareness about infertility and ART services which is likely to escalate the region as a promising contender in in vitro fertilization market.
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
EMD Serono, Inc. (Merck KGaA), Cook Medical LLC, Bayer AG., Vitrolife EMD Serono, Inc. Thermo Fisher Scientific, Ferring B.V., Genea, Biomedx, The Cooper Companies, FUJIFILM IrvineScientific Merck & Co,,Inc and other key market players.
Recent Developments Of The In Vitro Fertilization Market
June 2023: Life Whisperer platform, an AI-powered tool that supports clinical decision-making in IVF procedures., Fujifilm Irvine Scientific.
May 2023: Merck KGaA also unveils its "Fertility Counts" program aimed to combat the social and economic impact from low fertility rates in Asia Pacific.
May 2023: Ovation Fertility is merged with US Fertility to form an expanded platform of further developed fertility care and IVF services throughout the United States.
April 2023: Boston IVF Secures Three-Year Pact with Cryoport for Safe and Efficient Passage of Reproductive Materials in U.S.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 18.82 billion |
| Market Size by 2032 | US$ 35.83 Billion |
| CAGR | CAGR of 7.47% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments |
|
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | EMD Serono, Inc. (Merck KGaA), Cook Medical LLC, Bayer AG., Vitrolife EMD Serono, Inc. Thermo Fisher Scientific, Ferring B.V., Genea, Biomedx, The Cooper Companies, FUJIFILM IrvineScientific Merck & Co,,Inc |
Ans. The In Vitro Fertilization (IVF) market size was valued at US$ 18.83 billion in 2023.
Ans. The report is divided into three segments: By Procedure Type, By Instrument, By Providers
Ans. Some of the main drivers are as the age between first and foremost mothers is growing, Fertility decreases, the number of fertility clinics in the world is growing.
Ans. Europe is the largest market in In Vitro Fertilization (IVF) Market.
Ans. The In Vitro Fertilization (IVF) Market is to grow at a CAGR of 7.47% over the forecast period 2024-2032.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Porter’s 5 Forces Model
6. Pest Analysis
7. In Vitro Fertilization (IVF) Market Segmentation, By Instrument
7.1 Introduction
7.2 Disposable Devices
7.3 Culture Media
7.3.1 Cryopreservation Media
7.3.2 Embryo Culture Media
7.3.3 Ovum Processing Media
7.3.4 Sperm Processing Media
7.4 Equipment
7.4.1 Sperm Analyzer Systems
7.4.2 Imaging Systems
7.4.3 Ovum Aspiration Pumps
7.4.4 Micromanipulator Systems
7.4.5 Incubators
7.4.6 Gas Analyzers
7.4.7 Laser Systems
7.4.8 Cryosystems
7.4.9 Sperm Separation Devices
7.4.10 IVF Cabinets
7.4.11 Anti-vibration Tables
7.4.12 Witness Systems
7.4.13 Other
8. In Vitro Fertilization (IVF) Market Segmentation, By Procedure Type
8.1 Introduction
8.2 Fresh Donor
8.3 Frozen Donor
8.4 Fresh Non-donor
8.5 Frozen Non-donor
9. In Vitro Fertilization (IVF) Market Segmentation, By Providers
9.1 Introduction
9.2 Fertility Clinics
9.3 Hospitals & Others Setting
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 Trend Analysis
10.2.2 North America In Vitro Fertilization (IVF) Market by Country
10.2.3 North America In Vitro Fertilization (IVF) Market By Instrument
10.2.4 North America In Vitro Fertilization (IVF) Market By Procedure Type
10.2.5 North America In Vitro Fertilization (IVF) Market By Providers
10.2.6 USA
10.2.6.1 USA In Vitro Fertilization (IVF) Market By Instrument
10.2.6.2 USA In Vitro Fertilization (IVF) Market By Procedure Type
10.2.6.3 USA In Vitro Fertilization (IVF) Market By Providers
10.2.7 Canada
10.2.7.1 Canada In Vitro Fertilization (IVF) Market By Instrument
10.2.7.2 Canada In Vitro Fertilization (IVF) Market By Procedure Type
10.2.7.3 Canada In Vitro Fertilization (IVF) Market By Providers
10.2.8 Mexico
10.2.8.1 Mexico In Vitro Fertilization (IVF) Market By Instrument
10.2.8.2 Mexico In Vitro Fertilization (IVF) Market By Procedure Type
10.2.8.3 Mexico In Vitro Fertilization (IVF) Market By Providers
10.3 Europe
10.3.1 Trend Analysis
10.3.2 Eastern Europe
10.3.2.1 Eastern Europe In Vitro Fertilization (IVF) Market by Country
10.3.2.2 Eastern Europe In Vitro Fertilization (IVF) Market By Instrument
10.3.2.3 Eastern Europe In Vitro Fertilization (IVF) Market By Procedure Type
10.3.2.4 Eastern Europe In Vitro Fertilization (IVF) Market By Providers
10.3.2.5 Poland
10.3.2.5.1 Poland In Vitro Fertilization (IVF) Market By Instrument
10.3.2.5.2 Poland In Vitro Fertilization (IVF) Market By Procedure Type
10.3.2.5.3 Poland In Vitro Fertilization (IVF) Market By Providers
10.3.2.6 Romania
10.3.2.6.1 Romania In Vitro Fertilization (IVF) Market By Instrument
10.3.2.6.2 Romania In Vitro Fertilization (IVF) Market By Procedure Type
10.3.2.6.4 Romania In Vitro Fertilization (IVF) Market By Providers
10.3.2.7 Hungary
10.3.2.7.1 Hungary In Vitro Fertilization (IVF) Market By Instrument
10.3.2.7.2 Hungary In Vitro Fertilization (IVF) Market By Procedure Type
10.3.2.7.3 Hungary In Vitro Fertilization (IVF) Market By Providers
10.3.2.8 Turkey
10.3.2.8.1 Turkey In Vitro Fertilization (IVF) Market By Instrument
10.3.2.8.2 Turkey In Vitro Fertilization (IVF) Market By Procedure Type
10.3.2.8.3 Turkey In Vitro Fertilization (IVF) Market By Providers
10.3.2.9 Rest of Eastern Europe
10.3.2.9.1 Rest of Eastern Europe In Vitro Fertilization (IVF) Market By Instrument
10.3.2.9.2 Rest of Eastern Europe In Vitro Fertilization (IVF) Market By Procedure Type
10.3.2.9.3 Rest of Eastern Europe In Vitro Fertilization (IVF) Market By Providers
10.3.3 Western Europe
10.3.3.1 Western Europe In Vitro Fertilization (IVF) Market by Country
10.3.3.2 Western Europe In Vitro Fertilization (IVF) Market By Instrument
10.3.3.3 Western Europe In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.4 Western Europe In Vitro Fertilization (IVF) Market By Providers
10.3.3.5 Germany
10.3.3.5.1 Germany In Vitro Fertilization (IVF) Market By Instrument
10.3.3.5.2 Germany In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.5.3 Germany In Vitro Fertilization (IVF) Market By Providers
10.3.3.6 France
10.3.3.6.1 France In Vitro Fertilization (IVF) Market By Instrument
10.3.3.6.2 France In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.6.3 France In Vitro Fertilization (IVF) Market By Providers
10.3.3.7 UK
10.3.3.7.1 UK In Vitro Fertilization (IVF) Market By Instrument
10.3.3.7.2 UK In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.7.3 UK In Vitro Fertilization (IVF) Market By Providers
10.3.3.8 Italy
10.3.3.8.1 Italy In Vitro Fertilization (IVF) Market By Instrument
10.3.3.8.2 Italy In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.8.3 Italy In Vitro Fertilization (IVF) Market By Providers
10.3.3.9 Spain
10.3.3.9.1 Spain In Vitro Fertilization (IVF) Market By Instrument
10.3.3.9.2 Spain In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.9.3 Spain In Vitro Fertilization (IVF) Market By Providers
10.3.3.10 Netherlands
10.3.3.10.1 Netherlands In Vitro Fertilization (IVF) Market By Instrument
10.3.3.10.2 Netherlands In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.10.3 Netherlands In Vitro Fertilization (IVF) Market By Providers
10.3.3.11 Switzerland
10.3.3.11.1 Switzerland In Vitro Fertilization (IVF) Market By Instrument
10.3.3.11.2 Switzerland In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.11.3 Switzerland In Vitro Fertilization (IVF) Market By Providers
10.3.3.12 Austria
10.3.3.12.1 Austria In Vitro Fertilization (IVF) Market By Instrument
10.3.3.12.2 Austria In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.12.3 Austria In Vitro Fertilization (IVF) Market By Providers
10.3.3.13 Rest of Western Europe
10.3.3.13.1 Rest of Western Europe In Vitro Fertilization (IVF) Market By Instrument
10.3.3.13.2 Rest of Western Europe In Vitro Fertilization (IVF) Market By Procedure Type
10.3.3.13.3 Rest of Western Europe In Vitro Fertilization (IVF) Market By Providers
10.4 Asia-Pacific
10.4.1 Trend Analysis
10.4.2 Asia-Pacific In Vitro Fertilization (IVF) Market by Country
10.4.3 Asia-Pacific In Vitro Fertilization (IVF) Market By Instrument
10.4.4 Asia-Pacific In Vitro Fertilization (IVF) Market By Procedure Type
10.4.5 Asia-Pacific In Vitro Fertilization (IVF) Market By Providers
10.4.6 China
10.4.6.1 China In Vitro Fertilization (IVF) Market By Instrument
10.4.6.2 China In Vitro Fertilization (IVF) Market By Procedure Type
10.4.6.3 China In Vitro Fertilization (IVF) Market By Providers
10.4.7 India
10.4.7.1 India In Vitro Fertilization (IVF) Market By Instrument
10.4.7.2 India In Vitro Fertilization (IVF) Market By Procedure Type
10.4.7.3 India In Vitro Fertilization (IVF) Market By Providers
10.4.8 Japan
10.4.8.1 Japan In Vitro Fertilization (IVF) Market By Instrument
10.4.8.2 Japan In Vitro Fertilization (IVF) Market By Procedure Type
10.4.8.3 Japan In Vitro Fertilization (IVF) Market By Providers
10.4.9 South Korea
10.4.9.1 South Korea In Vitro Fertilization (IVF) Market By Instrument
10.4.9.2 South Korea In Vitro Fertilization (IVF) Market By Procedure Type
10.4.9.3 South Korea In Vitro Fertilization (IVF) Market By Providers
10.4.10 Vietnam
10.4.10.1 Vietnam In Vitro Fertilization (IVF) Market By Instrument
10.4.10.2 Vietnam In Vitro Fertilization (IVF) Market By Procedure Type
10.4.10.3 Vietnam In Vitro Fertilization (IVF) Market By Providers
10.4.11 Singapore
10.4.11.1 Singapore In Vitro Fertilization (IVF) Market By Instrument
10.4.11.2 Singapore In Vitro Fertilization (IVF) Market By Procedure Type
10.4.11.3 Singapore In Vitro Fertilization (IVF) Market By Providers
10.4.12 Australia
10.4.12.1 Australia In Vitro Fertilization (IVF) Market By Instrument
10.4.12.2 Australia In Vitro Fertilization (IVF) Market By Procedure Type
10.4.12.3 Australia In Vitro Fertilization (IVF) Market By Providers
10.4.13 Rest of Asia-Pacific
10.4.13.1 Rest of Asia-Pacific In Vitro Fertilization (IVF) Market By Instrument
10.4.13.2 Rest of Asia-Pacific In Vitro Fertilization (IVF) Market By Procedure Type
10.4.13.3 Rest of Asia-Pacific In Vitro Fertilization (IVF) Market By Providers
10.5 Middle East & Africa
10.5.1 Trend Analysis
10.5.2 Middle East
10.5.2.1 Middle East In Vitro Fertilization (IVF) Market by Country
10.5.2.2 Middle East In Vitro Fertilization (IVF) Market By Instrument
10.5.2.3 Middle East In Vitro Fertilization (IVF) Market By Procedure Type
10.5.2.4 Middle East In Vitro Fertilization (IVF) Market By Providers
10.5.2.5 UAE
10.5.2.5.1 UAE In Vitro Fertilization (IVF) Market By Instrument
10.5.2.5.2 UAE In Vitro Fertilization (IVF) Market By Procedure Type
10.5.2.5.3 UAE In Vitro Fertilization (IVF) Market By Providers
10.5.2.6 Egypt
10.5.2.6.1 Egypt In Vitro Fertilization (IVF) Market By Instrument
10.5.2.6.2 Egypt In Vitro Fertilization (IVF) Market By Procedure Type
10.5.2.6.3 Egypt In Vitro Fertilization (IVF) Market By Providers
10.5.2.7 Saudi Arabia
10.5.2.7.1 Saudi Arabia In Vitro Fertilization (IVF) Market By Instrument
10.5.2.7.2 Saudi Arabia In Vitro Fertilization (IVF) Market By Procedure Type
10.5.2.7.3 Saudi Arabia In Vitro Fertilization (IVF) Market By Providers
10.5.2.8 Qatar
10.5.2.8.1 Qatar In Vitro Fertilization (IVF) Market By Instrument
10.5.2.8.2 Qatar In Vitro Fertilization (IVF) Market By Procedure Type
10.5.2.8.3 Qatar In Vitro Fertilization (IVF) Market By Providers
10.5.2.9 Rest of Middle East
10.5.2.9.1 Rest of Middle East In Vitro Fertilization (IVF) Market By Instrument
10.5.2.9.2 Rest of Middle East In Vitro Fertilization (IVF) Market By Procedure Type
10.5.2.9.3 Rest of Middle East In Vitro Fertilization (IVF) Market By Providers
10.5.3 Africa
10.5.3.1 Africa In Vitro Fertilization (IVF) Market by Country
10.5.3.2 Africa In Vitro Fertilization (IVF) Market By Instrument
10.5.3.3 Africa In Vitro Fertilization (IVF) Market By Procedure Type
10.5.3.4 Africa In Vitro Fertilization (IVF) Market By Providers
10.5.3.5 Nigeria
10.5.3.5.1 Nigeria In Vitro Fertilization (IVF) Market By Instrument
10.5.3.5.2 Nigeria In Vitro Fertilization (IVF) Market By Procedure Type
10.5.3.5.3 Nigeria In Vitro Fertilization (IVF) Market By Providers
10.5.3.6 South Africa
10.5.3.6.1 South Africa In Vitro Fertilization (IVF) Market By Instrument
10.5.3.6.2 South Africa In Vitro Fertilization (IVF) Market By Procedure Type
10.5.3.6.3 South Africa In Vitro Fertilization (IVF) Market By Providers
10.5.3.7 Rest of Africa
10.5.3.7.1 Rest of Africa In Vitro Fertilization (IVF) Market By Instrument
10.5.3.7.2 Rest of Africa In Vitro Fertilization (IVF) Market By Procedure Type
10.5.3.7.3 Rest of Africa In Vitro Fertilization (IVF) Market By Providers
10.6 Latin America
10.6.1 Trend Analysis
10.6.2 Latin America In Vitro Fertilization (IVF) Market by country
10.6.3 Latin America In Vitro Fertilization (IVF) Market By Instrument
10.6.4 Latin America In Vitro Fertilization (IVF) Market By Procedure Type
10.6.5 Latin America In Vitro Fertilization (IVF) Market By Providers
10.6.6 Brazil
10.6.6.1 Brazil In Vitro Fertilization (IVF) Market By Instrument
10.6.6.2 Brazil In Vitro Fertilization (IVF) Market By Procedure Type
10.6.6.3 Brazil In Vitro Fertilization (IVF) Market By Providers
10.6.7 Argentina
10.6.7.1 Argentina In Vitro Fertilization (IVF) Market By Instrument
10.6.7.2 Argentina In Vitro Fertilization (IVF) Market By Procedure Type
10.6.7.3 Argentina In Vitro Fertilization (IVF) Market By Providers
10.6.8 Colombia
10.6.8.1 Colombia In Vitro Fertilization (IVF) Market By Instrument
10.6.8.2 Colombia In Vitro Fertilization (IVF) Market By Procedure Type
10.6.8.3 Colombia In Vitro Fertilization (IVF) Market By Providers
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America In Vitro Fertilization (IVF) Market By Instrument
10.6.9.2 Rest of Latin America In Vitro Fertilization (IVF) Market By Procedure Type
10.6.9.3 Rest of Latin America In Vitro Fertilization (IVF) Market By Providers
11. Company Profiles
11.1 EMD Serono, Inc. (Merck KGaA)
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 The SNS View
11.2 Cook Medical LLC
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 The SNS View
11.3 Bayer AG.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 The SNS View
11.4 Vitrolife EMD Serono, Inc.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 The SNS View
11.5 Thermo Fisher Scientific
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 The SNS View
11.6 Ferring B.V.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 The SNS View
11.7 Genea
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 The SNS View
11.8 Biomedx
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 The SNS View
11.9 The Cooper Companies
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 The SNS View
11.10 FUJIFILM
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. Use Case and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Blockchain Technology in Healthcare Market Size was valued at USD 3.3 billion in 2023 and is expected to reach USD 214.44 billion by 2031, and grow at a CAGR of 68.5% over the forecast period 2024-2031.
The Process Analytical Technology Market size was estimated at USD 3.62 billion in 2023 and is expected to reach USD 11.78 billion by 2032 with a growing CAGR of 14.01% during the forecast period of 2024-2032.
The Neuroendoscopy Market size is projected to grow from US$ 151.07 million in 2023 to US$ 237.05 million by 2031, at a CAGR of 5.8% during the forecast period 2023-2031.
The Spinal Muscular Atrophy Treatment Market size was estimated at USD 4.48 billion in 2023 and is expected to reach USD 7.65 billion by 2031 at a CAGR of 6.9% during the forecast period of 2024-2031.
The Healthcare Contract Research Organization Market Size was valued at USD 50.5 billion in 2023 and is expected to reach USD 88.07 billion by 2031, and grow at a CAGR of 7.2% over the forecast period 2024-2031.
The Digital Clinical Trials Market was valued at USD 8.70 billion in 2023 and is expected to reach at USD 13.86 billion in 2031 and grow at a CAGR of 6 % over the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
